Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Plasminogen | ||
Ligand | BDBM50060707 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_155252 (CHEMBL764405) | ||
Ki | >1000000±n/a nM | ||
Citation | Tucker, TJ; Lumma, WC; Lewis, SD; Gardell, SJ; Lucas, BJ; Sisko, JT; Lynch, JJ; Lyle, EA; Baskin, EP; Woltmann, RF; Appleby, SD; Chen, IW; Dancheck, KB; Naylor-Olsen, AM; Krueger, JA; Cooper, CM; Vacca, JP Synthesis of a series of potent and orally bioavailable thrombin inhibitors that utilize 3,3-disubstituted propionic acid derivatives in the P3 position. J Med Chem40:3687-93 (1997) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Plasminogen | |||
Name: | Plasminogen | ||
Synonyms: | Activation peptide | Angiostatin | PLG | PLMN_HUMAN | Plasmin | Plasmin heavy chain A | Plasmin heavy chain A, short form | Plasmin light chain B | ||
Type: | Enzyme | ||
Mol. Mass.: | 90579.18 | ||
Organism: | Homo sapiens (Human) | ||
Description: | n/a | ||
Residue: | 810 | ||
Sequence: |
| ||
BDBM50060707 | |||
n/a | |||
Name | BDBM50060707 | ||
Synonyms: | (S)-1-(3-Phenyl-3-pyridin-3-yl-propionyl)-pyrrolidine-2-carboxylic acid (4-amino-cyclohexylmethyl)-amide; TFA | CHEMBL333238 | ||
Type | Small organic molecule | ||
Emp. Form. | C26H34N4O2 | ||
Mol. Mass. | 434.5738 | ||
SMILES | NC1CCC(CNC(=O)[C@@H]2CCCN2C(=O)CC(c2ccccc2)c2cccnc2)CC1 |wU:9.8,(5.07,-10.18,;4.11,-8.99,;3.7,-7.74,;4.34,-6.14,;3.02,-5.37,;1.62,-4.73,;1.45,-3.19,;.06,-2.58,;-1.19,-3.48,;-.1,-1.04,;1.04,-.01,;.42,1.4,;-1.11,1.24,;-1.43,-.27,;-2.84,-.88,;-3.01,-2.42,;-4.07,.02,;-4.1,1.56,;-2.76,2.33,;-1.41,1.56,;-.09,2.33,;-.09,3.87,;-1.43,4.64,;-2.76,3.87,;-5.42,2.33,;-5.42,3.87,;-6.74,4.64,;-8.09,3.87,;-8.07,2.33,;-6.74,1.56,;3.41,-6.52,;2.79,-8.22,)| | ||
Structure |